November 29, 2013 4:19 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top drug related products stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.Perrigo Company (NASDAQ: PRGO) is likely to earn $7.96 per share in the next year ending June, 2015. Perrigo's trailing-twelve-month ROE is 20.19%.Herbalife (NYSE: HLF) may earn $5.73 per share in the next year ending December, 2014. Herbalife's trailing-twelve-month operating margin is 15.45%.USANA Health Sciences (NYSE: USNA) is projected to earn $5.68 per share for the next year ending December, 2014. USANA Health's trailing-twelve-month revenue is $700.44 million.Prestige Brands Holdings (NYSE: PBH) is expected to earn $1.83 per share over the next year ending March, 2015. Prestige Brands had $26.83 million in total cash for the latest quarter.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.